Back to Browse Journals » International Journal of General Medicine » Volume 4

Seasonal variation of vitamin D and HbA1c levels in patients with type 1 diabetes mellitus in the Middle East

Authors El Baba K, Zantout MS, Akel R, Azar ST

Published Date September 2011 Volume 2011:4 Pages 635—638

DOI http://dx.doi.org/10.2147/IJGM.S23548

Published 6 September 2011

Khaled El Baba, Mira S Zantout, Randa Akel, Sami T Azar
Department of Internal Medicine, Division of Endocrinology and Metabolism, American University of Beirut Medical Center, Beirut, Lebanon

Introduction: The discovery that many tissues express the vitamin D receptor and are able to transform the 25-hydroxyvitamin D into 1,25-dihydroxyvitamin D (active metabolite) has led to the hypothesis that vitamin D could have a role in the pathogenesis and prevention of diabetes mellitus. Accumulating evidence has linked vitamin D deficiency with immunological disturbance in type 1 diabetes mellitus. Several epidemiological studies have shown lower serum 25-hydroxyvitamin D concentrations in diabetic individuals compared to nondiabetic individuals.
Patients and methods: A total of 105 Lebanese patients with type 1 diabetes mellitus were recruited. Levels of HbA1c and vitamin D were recorded during two phases with phase 1 being the period from June–September 2009 and phase 2 from January–April 2009.
Results: Vitamin D levels at the end of sunny season (phase 2), reflecting the previous sunny months, were found to be higher than in the early summer season (phase 1) reflecting the previous cloudy months season, with a mean change of 0.70 ± 6.87 ng/mL (P = 0.029). HbA1c levels were higher in phase 2 than in phase 1 with an increase of 0.175% ± 1.46% (P = 0.113).
Conclusion: Vitamin D levels were higher at the end of the sunny season than at the end of cloudy season. HbA1c was also lower (but not significantly so) in the early summer season (cloudy months). There was a weak correlation between seasonal changes of vitamin D levels and the control of blood glucose as monitored by HbA1c in a cohort of Lebanese patients with type 1 diabetes mellitus.

Keywords: type 1 diabetes, vitamin D, HbA1c, seasonal variation

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Thyroid dysfunction in pregnancy

El Baba KA, Azar ST

International Journal of General Medicine 2012, 5:227-230

Published Date: 6 March 2012

Readers of this article also read:

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

Lipid profile of regular blood donors

Uche EI, Adediran A, Damulak OD, Adeyemo TA, Akinbami AA, Akanmu AS

Journal of Blood Medicine 2013, 4:39-42

Published Date: 10 May 2013

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011

Is vitamin D status a determining factor for metabolic syndrome? A case-control study

Salekzamani S, Neyestani TR, Alavi-Majd H, Houshiarrad A, Kalayi A, Shariatzadeh N, Gharavi A

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:205-212

Published Date: 10 June 2011